Ahmed I.M.,Tahir Y.F.,Nour S.M.,Suliman M.A.,M. A. M.A.,Res Sudan. Trop. Plant .2020 .Traditional use of medicinal plants among the Barti tribe community in Fangoga area. , 7(2) : 517-521.
Alam S.,Sarker M.,Rahman M.,Afrin S.,Richi C.,Zhao J.R.,Zhou I.N.,Mohamed I.N. .2021 .Traditional herbal medicines, bioactive metabolites, and plant products against COVID-19: Update on clinical trials and mechanism of actions. Front, 12(1248) : 1-20.
Alhazmi H.A.,Najmi A.,Javed S.A.,Sultana S.,Makeen H.A.,Meraya A.M.,Ahsan W.,Mohan S.,Taha M.M.E.,Khalid A. .2021 .Medicinal plants and isolated molecules demonstrating immunomodulation activity as potential alternative therapies for viral diseases including COVID-19. , 637553(637553) : 1-24.
Anand A.V.,Balamuralikrishnan B.,Kaviya M.,Bharathi K.,Parithathvi A.,Arun M.,Senthilkumar N.,Velayuthaprabhu S.,Saradhadevi M.,Al-Dhabi N.A.,Arasu M.V.,M.I. Yatoo M.V.,Tiwari R.,Dhama K. .2021 .Herbs to Combat Viral Pathogens Including SARS-CoV-2. , 26(6) : 1-28.
Aronoff D.M.,Neilson E.G. .2001 .Antipyretics: mechanisms of action and clinical use in fever suppression. Amer. J. Med, 111(4) : 304-315.
Arshad B. .2022 .Repurposed traditional medicinal plants as an important weapon for fighting against COVID-19: Pakistani perspective. , 54(2) : 1495-1505.
Arshad B.,Bhatti K.P.,Zaman W.,Ullah F.,Nazeer A.,Saqib S. .2021 .Insights into Off-Label therapeutic strategies against mild and severe COVID-19 infection. , 1469(4) : 1484-1484.
Ashraf S.,Ashraf S.,Akmal R.,Ashraf M.,Kalsoom L.,Maqsood A.,Imran M.A.,Ashraf S.,Siddiqui U.N.,Ghufran M.,Izhar M. .2021 .Prophylactic potential of honey and Nigella sativa L. against hospital and community-based SARS-CoV-2 spread: a structured summary of a study protocol for a Randomized controlled trial. Trials., 22(1) : 1-3.
Ashraf S.,Ashraf M.,Ashraf M.A.,Imran L.,Kalsoom U.N.,Siddiqui I.,Farooq Z.,Habib S.,Ashraf M.,Ghufran M.K.,Akram S.,Siddique S. .2020 .Honey and Nigella sativa against COVID-19 in Pakistan (HNS-COVID-PK): A multicenter placebo-controlled randomized clinical trial. Phytotherapy Research, 37(2) : 627-644.
Asif M.,Saleem M.,Saadullah M.,Yaseen H.,Zarzour R. Al .2020 .COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties. , 10(5) : 1153-1161.
Baildya N.,Khan A.A.,Ghosh N.N.,Dutta T.,Chattopadhyay A.P. .2021 .Screening of potential drug from Azadirachta Indica (Neem) extracts for SARS-CoV-2: an insight from molecular docking and MD-simulation studies. J. Mol. Struct, 1227 : 129390.
Bornstein S.R.,Rubino F.,Khunti K.,Mingrone G.,Hopkins D.,Birkenfeld A.L.,Amiel B. Boehm S.,Holt R.I.G.,Skyler J.S.,DeVries J.H.,Eckel R.H.,Zimmet P.,Alberti K.G.,Vidal J.,Geloneze B.,Chan J.C.,Ji L.,Ludwig B. .2020 .Practical recommendations for the management of diabetes in patients with COVID-19. , 8587(20) : 30152-2.
Chen X.,Jiang Q.,Ma Z.,Ling J.,Hu W.,Cao Q.,Mo P.,Yao L.,Yang R.,Gao S.,Gui X.,Hou W.,Xiong Y.,Li J.,Zhang Y. .2020 .Clinical characteristics of hospitalized patients with SARS-CoV-2 and hepatitis B virus co-infection. Virol, 35(6) : 842-845.
Dermawan D.,Prabowo B.A.,Rakhmadina C.A. .2021 .In silico study of medicinal plants with cyclodextrin inclusion complex as the potential inhibitors against SARS-CoV-2 main protease (Mpro) and spike (S) receptor. Inform. Med, 25 : 100645.
Diao B.,Wang C.,Tan Y.,Chen X.,Liu Y.,Ning L.,Chen L.,Li M.,Liu Y.,Wang G.,Yuan Z.,Feng Z.,Zhang Y.,Wu Y.,Chen Y. .2020 .Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). , 00827(827) : 1-7.
Djomkam A.L.Z.,Olwal C.O.,Sala T.B.,Paemka L. .2020 .Commentary: SARS-CoV-2 cell entry depends on ACE-2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Front Oncol., 10(1448) : 1-3.
Dutta M.M.,Nezam S.,Chowdhury A.,Rakib A.,Paul S.A.,Sami Z.,Uddin S.,Rana S.,Hossain Y.,Effendi R.,Idroes T.,Tallei A.M.,Alqahtani T.B.,Emran T.B. .2021 .Appraisals of the Bangladeshi medicinal plant Calotropis gigantea used by folk medicine practitioners in the management of COVID19: a biochemical and computational approach. Mol. Biosci, 625391(481) : 1-16.
Gallelli L.,Zhang L.,Wang T.,Fu F. .2020 .Severe acute lung injury related to COVID‐19 infection: a review and the possible role for Escin. J. Clin. Pharmacol, 60(7) : 815-825.
Garg S.,Anand A.,Lamba Y.,Roy A. .2020 .Molecular docking analysis of selected phytochemicals against SARSCoV-2 Mpro receptor. , 33(4) : 766-781.
Gautret P.,Jarrot P.A.,Camoin-Jau L.,Colson P.,Fenollar F.,Leone M.,Scola B.L.,Devaux C.,Gaubert J.Y.,Mege J.L.,Vitte J.,Melenotte C.,Rolain J.M.,Parola P.,Lagier J.C.,Brouqui P.,Raoult D. .2021 .Natural history of COVID-19 and therapeutic options. Exp. Rev. Clin. Immunol, 1847640(12) : 1159-1184.
Ghosh R.,Chakraborty A.,Biswas A.,Chowdhuri S. .2021 .Identification of alkaloids from Justicia adhatoda as potent SARS CoV-2 main protease inhibitors: An in silico perspective. J. Mol. Struct, 1229 : 129489.
Gil C.,Ginex T.,Maestro I.,Nozal V.,Barrado-Gil L.,Cuesta-Geijo M.A.,Urquiza J.,Ramírez D.,Alonso C.,Campillo N.E.,Martinez A. .2020 .drug targets and potential treatments. J. Med, 10(21) : 12359-12386.
Gowrishankar S.,Muthumanickam A.,Kamaladevi C.,Karthika R.,Jothi P.,Boomi D.,Maniazhagu S.K.,Pandian S.K. .2021 .Promising phytochemicals of traditional Indian herbal steam inhalation therapy to combat COVID-19-An in silico study. Food Chem, 148(111966) : 1-13.
Grant M.C. ,L. Geoghegan M. Arbyn Z.,Mohammed L.,McGuinness E.L.,Clarke R.G.,Wade R.G. .2020 .A systematic review and meta-analysis of 148 studies from 9 countries. PloS one. , 15(6) : e0234765.
Haq F.U.,Roman M.,Ahmad K.,Rahman S.U.,Shah S.,Suleman N.,Ullah S.,Ahmad I.,Ullah W. .2020 .Artemisia annua: Trials are needed for COVID-19. PTR, 34(10) : 2423-2424.
Henderson L.A.,Canna S.W.,Friedman K.G.,Gorelik M.,Lapidus S.K.,Bassiri H.,Behrens E.M.,Ferris A.,Kernan K.F.,Schulert G.S.,Seo P.,M.B.F Son A.H.,Tremoulet R.,Yeung A.S.,Mudano A.S.,Turner D.R.,Karp J.J.,Mehta J.J.,Rheumatol Arthritis,(Hoboken N.J. .2020 .American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 1. , 72(11) : 1791-1805.
Hosoki K.,Chakraborty A.,Sur S. .2020 .Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective. J. Allergy Clin. Immunol, 146(2) : 285-299.
Idrees S.,Khan N.H.,Memon Z.,Zhang Z. .2021 .Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A MiniReview. Curr. Pharm. Biotechnol, 22(4) : 444-450.
Jalali A.,Dabaghian F.,Akbrialiabad H.,Foroughinia F.,Zarshenas M.M. .2021 .A pharmacology‐based comprehensive review on medicinal plants and phytoactive constituents possibly effective in the management of COVID‐19. , 35(4) : 1925-1938.
Kapepula P.M.,Kabengele J.K.,Kingombe M.,F. Van Bambeke M.,Tulkens P.M.,Kishabongo A.S.,Decloedt E.,Zumla A.,Tiberi S.,Suleman F.,Tshilolo L.,Muyembe-TamFum J.J.,Zumla A.,Nachega J.B. .2020 .Artemisia spp. Derivatives for COVID-19 Treatment: Anecdotal use, political hype, treatment potential, challenges, and road map to randomized clinical trials. Amer. J. Trop. Med, 103(3) : 0820-964.
Kar P.,Kumar V.,Vellingiri B.,Sen A.,Jaishee N.,Anandraj A.,Malhotra H.,Bhattacharyya S.,Mukhopadhyay S.,Kinoshita M.,Govindasamy V.,Roy A.,Naidoo D.,Subramaniam M.D. .2022 .Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation. J. Biomol. Struct. Dyn, 40(10) : 4532-4542.
Khanna K.,Kohli S.K.,Kaur R.,Bhardwaj A.,Bhardwaj V.,Ohri P.A.,Sharmaad A.,Ahmade A.,Bhardwaja R.,P. Ahmad R. .2021 .Herbal immune-boosters: substantial warriors of pandemic Covid-19 battle. , 85(153361) : 1-7.
Kim J.S.,Lee J.Y.,Yang J.W.,Lee K.H.,Effenberger M.,Szpirt W.,Kronbichler A.,Shin J.I. .2021 .Immunopathogenesis and treatment of cytokine storm in COVID-19. , 11(1) : 316-329.
Kloc M.,Ghobrial R.M.,Kuchar E.,Lewicki S.,Kubiak J.Z. .2020 .Development of child immunity in the context of COVID-19 pandemic. Clin. Immunol, 108510(108510) : 1-4.
Koshak A.E.,Koshak E.A.,Mobeireek A.F.,Badawi M.A.,Wali S.O.,Malibary H.M.,Atwah A.F.,M.M. Alhamdan R.A.,Almalki T.A.,Madani T.A. .2020 .Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomized, controlled, clinical trial. Trials, 21(1) : 1-2.
Kang Li Q and C. .2020 .Progress in developing inhibitors of SARS-CoV-2 3C-like protease. Microorganisms, 8(1250) : 1-18.
Li Y.,Xia L. .2020 .Coronavirus disease 2019 (COVID-19): Role of chest CT in diagnosis and management. Amer. J. Roentgenol., 214(6) : 1280-1286.
Magzoub M. .2020 .Life style guideline of ginger (Zingiber officinale Roscoe officinale) as prophylaxis and treatment for coronaviruses (SARS-CoV-2) infection (COVID-19). Saudi J. Biomed. Res., 5(6) : 125-127.
Maiti S.,Banerjee A.,Nazmeen A.,Kanwar M.,Das S. .2020 .Active-site Molecular docking of Nigellidine with nucleocapsid-NSP2-MPro of COVID-19 and to human IL1R-IL6R and strong antioxidant role of Nigella-sativa in experimental rats. J. Drug Target, : 1-23.
Mehta P.,D.F. McAuley M.,Brown R.S.,Tattersall J.J.,Manson J.J. .2020 .consider cytokine storm syndromes and immunosuppression. , 395(10229) : 1033-1034.
Mirzaie A.,Halaji M.,Dehkordi F.S.,Ranjbar R.,Noorbazargan H. .2020 .A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19). Complement. Ther. Clin. Pract, 40 : 101214.
Mody V.,Ho J.,Wills S.,Mawri A.,Lawson L.,Ebert M.C.,M.C. M.C.,Fortin G.M.,Rayalam S.,Taval S. .2021 .Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents. Comm. Biol, 4(1) : 1-10.
Mondal P.,J. Natesh A.A.,Abdul Salam S.,Thiyagarajan M.S.,Meeran M.S. .2020 .Traditional medicinal plants against replication, maturation and transmission targets of SARSCoV-2: computational investigation. J. Biomol. Struct., 1842246 : 1-18.
Nair M.S.,Huang Y.,Fidock D.A.,Polyak S.J.,Wagoner J.,Towler M.J.,Weathers P.J. .2021 .Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants. J. Ethnopharmacol., 274(114016) : 1-8.
Narkhede R.R.,Pise A.V.,Cheke R.S.,Shinde S.D. .2020 .Recognition of natural products as potential inhibitors of COVID-19 main protease (Mpro): In-silico evidences. Nat. Prod, 10(5) : 297-306.
Natesh J.,Mondal P.,Kaur B.,Salam A.A.A.,Kasilingam S.,Meeran S.M. .2021 .Promising phytochemicals of traditional Himalayan medicinal plants against putative replication and transmission targets of SARS-CoV-2 by computational investigation. Comput. Biol. Med, 104383 : 104383.
NCT04345549. .2020 .Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak by NMP Medical Research Institute. , : .
NCT04357990. .2020 .Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19 (KONS-COVID19). ClinicalTrials, : .
NCT04480398. .2020 .Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients. NCT04480398&draw=2&rank=1., : .
NCT04542876. .2020 .Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection. NCT04542876&draw =2&rank=1., : .
NCT04553705. ,Sativa Nigella .2020 .Artemisinin, Febrifugine on Immunity of Patients With (COVID-19). , 3 : .
NCT04621903. ,Moderate COVID .2020 .A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-. : Community Based Participatory Research, : .
NCT04716647. .2021 .term=NC T04716647&draw=2&rank1.. , : .
NCT04767087. .2021 .Honey and Nigella Sativa in COVID-19 Prophylaxis (HNS-COVID-PK). NCT04767087&draw=2&rank=1., : .
NCT04914377. ,Participants (BOSS) ClinicalTrials.Gov .2021 .To Evaluate the Safety and Efficacy of TQ Formula in Covid-. NCT04914377 & draw=2&rank=1., : .
NCT04914767. .2021 .Nigella 5 in the Treatment of SARS COV2 (COVID-19) (Nigelle5) ClinicalTrials. NCT04914767&draw=2&rank=1., : .
NCT04920773. .2021 .Community-based Post-Exposure Prophylaxis for COVID-19. NCT04920773&draw=2&rank=1., : .
NCT04981743. .2021 .2 6+Nigella+Sativa& cond=Corona +Virus+Infection &draw=2&rank=2. , 10 : .
Pandamooz S.,Jurek B.,Meinung C.P.,Baharvand Z.,Shahem-Abadi A. Sahebi,Haerteis S.,Miyan J.A.,Downing J.,Dianatpour M.,Borhani-Haghighi and M.S Salehi A. .2022 .Experimental models of SARS-CoV-2 infection: possible platforms to study COVID-19 pathogenesis and potential treatments. Annu. Rev. Pharmacol. Toxicol., 62 : 25-53.
Parida P.K.,Paul D.,Chakravorty D. .2020 .The natural way forward: molecular dynamics simulation analysis of phytochemicals from Indian medicinal plants as potential inhibitors of SARS‐CoV‐2 targets. , 34(12) : 3420-3433.
Patankar S.B.,Gorde K. A.,Suryawanshi K.,Soni P.,Shah T.,Patankar S.,Jha D.,Raje R.,Rangnekar H. .2022 .Efficacy and Safety of Polyherbal formulation as an add-on to the standard of care in mild to moderate COVID-19: A randomized, double-blind, placebo-controlled trial. J-AIM, 13(100653) : 1-8.
Pillay T.S. .2020 .Gene of the month: the 2019-nCoV/SARSCoV-2 novel coronavirus spike protein. J. Clin. Pathol, 73(7) : 366-369.
Prasanth D.S.N.B.K.,Murahari M.,Chandramohan V.,Panda S.P.,Atmakuri L.R.,Guntupalli C.,Biomol J. .2021 .In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2. , 39(13) : 4618-4632.
Rangnekar S.,Patankar K.,Suryawanshi P.,Soni P. .2020 .Safety and efficacy of herbal extracts to restore respiratory health and improve innate immunity in COVID-19 positive patients with mild to moderate severity: A structured summary of a study protocol for a randomized controlled trial. Trials, 21(1) : 1-3.
Rivero-Segura N.A,J.C. N.A .2021 .In Silico Screening of Natural Products Isolated from Mexican Herbal Medicines against COVID-19. , 11(216) : 1-12.
Safa O.,Hassani-Azad M.,Farashahinejad M.,Davoodian P.,Dadvand H.,Hassanipour S.,Fathalipour M. .2020 .Effects of Licorice on clinical symptoms and laboratory signs in moderately ill patients with pneumonia from COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials, 21(1) : 1-3.
Safa O.,Hassaniazad M.,Farashahinejad M.,Davoodian P.,Dadvand H.,Hassanipour S.,Fathalipour M. .2020 .Effects of Ginger on clinical manifestations and paraclinical features of patients with Severe Acute Respiratory Syndrome due to COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials, 21(1) : 1-2.
Shawky E,Nada A.A.,Ibrahim R.S. .2020 .Potential role of medicinal plants and their constituents in the mitigation of SARS-CoV-2: identifying related therapeutic targets using network pharmacology and molecular docking analyses. RSC Advances, 10(47) : 27961-27983.
Shree P.,Selvaraj C.,Singh S.K.,Chaube R.,Garg N.,Tripathi Y.B. .2022 .Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants-Withania somnifera (Ashwagandha), Giloy (Giloy) and Ocimum sanctum (Tulsi)-a molecular docking study. J. Biomol. Struct. Dyn., 40(1) : 190-203.
Sparke M.,Williams O.D. .2022 .Neoliberal disease: COVID-19, co-pathogenesis and global health insecurities. Environment and Planning A: Economy and Space, 54(1) : 15-32.
Tegen D.,Dessie K.,Damtie D. .2021 .Candidate antiCOVID-19 medicinal plants from Ethiopia: A review of plants traditionally used to treat viral diseases", EvidenceBased Complementary and Alternative Medicine. , : 1-20.
Tripathi M.K.,Singh P.,Sharma S.,Singh T.P.,Ethayathulla A.S.,Kaur P. .2021 .Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor. J. Biomol. Struct., 39(15) : 5668-5681.
Ul-Qamar S.M.,Alqahtani M.A.,Alamri L.L.,Chen L.L. .2020 .Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J. Pharm. Anal., 03(4) : 313-319.
Umar H.I.,Josiah S.S.,Saliu T.P.,Jimoh T.O.,Ajayi A.,Danjuma J.B. .2021 .In-silico analysis of the inhibition of the SARS-CoV-2 main protease by some active compounds from selected African plants. J. Taibah Univ. Medical Sci., 16(2) : 162-176.
Xu T.,Chen C.,Zhu Z.,Cui M.,Chen C.,Dai H.,Xue Y.,Infect Int. J. .2020 .Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19.. , 94 : 68-71.
Younis W.,Asif H.,Sharif A.,Riaz H.,Bukhari I.A.,Assiri A.M. .2018 .Traditional medicinal plants used for respiratory disorders in Pakistan: a review of the ethnomedicinal and pharmacological evidence. Chinese Med, 13(1) : 1-29.
Zhang Y.,Yu L.,Tang L.,Zhu M.,Jin Y.,Wang Z.,Li L. .2021 .A promising anti-cytokine-storm targeted therapy for COVID-19: the artificial-liver blood-purification system. Engin, 7(11) : 1-3.